Holdings (Monthly)
Guide ↗
Saratoga Health & Biotechnology Fund
· Saratoga Advantage Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Cardinal Health, Inc. | 14149Y108 | Feb 2026 | 3,429 | $786K | 6.77% | EC |
| 2 | Mckesson Corp. | 58155Q103 | Feb 2026 | 691 | $682K | 5.88% | EC |
| 3 | Amgen Inc. | 031162100 | Feb 2026 | 1,752 | $680K | 5.86% | EC |
| 4 | Cencora Inc | 03073E105 | Feb 2026 | 1,683 | $626K | 5.40% | EC |
| 5 | Jazz Pharmaceuticals PLC | G50871105 | Feb 2026 | 3,241 | $616K | 5.31% | EC |
| 6 | United Therapeutics Corporation | 91307C102 | Feb 2026 | 1,160 | $585K | 5.04% | EC |
| 7 | Novartis AG | 66987V109 | Feb 2026 | 3,140 | $529K | 4.56% | EC |
| 8 | Regeneron Pharmaceuticals, Inc. | 75886F107 | Feb 2026 | 670 | $524K | 4.51% | EC |
| 9 | Gilead Sciences Inc. | 375558103 | Feb 2026 | 3,068 | $457K | 3.94% | EC |
| 10 | Johnson & Johnson | 478160104 | Feb 2026 | 1,820 | $452K | 3.90% | EC |
| 11 | The Cigna Group | 125523100 | Feb 2026 | 1,371 | $397K | 3.42% | EC |
| 12 | Merck & Co., Inc | 58933Y105 | Feb 2026 | 3,206 | $397K | 3.42% | EC |
| 13 | Vertex Pharmaceuticals Incorporated | 92532F100 | Feb 2026 | 787 | $391K | 3.37% | EC |
| 14 | Intuitive Surgical Inc. | 46120E602 | Feb 2026 | 775 | $390K | 3.36% | EC |
| 15 | Thermo Fisher Scientific Inc | 883556102 | Feb 2026 | 708 | $369K | 3.18% | EC |
| 16 | Lantheus Holdings Inc | 516544103 | Feb 2026 | 4,900 | $367K | 3.16% | EC |
| 17 | Medpace Holdings Inc. | 58506Q109 | Feb 2026 | 790 | $357K | 3.07% | EC |
| 18 | Exelixis, Inc. | 30161Q104 | Feb 2026 | 7,945 | $350K | 3.02% | EC |
| 19 | National Healthcare Corporation | 635906100 | Feb 2026 | 2,112 | $345K | 2.97% | EC |
| 20 | Ensign Group Inc | 29358P101 | Feb 2026 | 1,499 | $321K | 2.77% | EC |
| 21 | Stryker Corporation | 863667101 | Feb 2026 | 825 | $320K | 2.75% | EC |
| 22 | Incyte Corporation. | 45337C102 | Feb 2026 | 3,132 | $317K | 2.73% | EC |
| 23 | Medtronic PLC | G5960L103 | Feb 2026 | 3,126 | $305K | 2.63% | EC |
| 24 | Dreyfus Instl Resv | 26200X100 | Feb 2026 | 293,661 | $294K | 2.53% | STIV |
| 25 | Labcorp Holdings Inc | 504922105 | Feb 2026 | 849 | $245K | 2.11% | EC |
| 26 | Eli Lilly & Co. | 532457108 | Feb 2026 | 200 | $210K | 1.81% | EC |
| 27 | Elevance Health Inc. | 036752103 | Feb 2026 | 433 | $139K | 1.19% | EC |
| 28 | Veeva Systems Inc | 922475108 | Feb 2026 | 700 | $127K | 1.10% | EC |
| 29 | Novo Nordisk A/S | 670100205 | Feb 2026 | 1,735 | $65K | 0.56% | EC |
| 30 | DREYFUS TREASURY OBLIGATIONS CASH MANAGEMENT | N/A | Feb 2026 | 0 | $0 | 0.00% | STIV |